These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 196397)

  • 1. Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation.
    zur Hausen H; Fresen KO
    Virology; 1977 Aug; 81(1):138-43. PubMed ID: 196397
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
    Dölken G; Klein G
    Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
    Rocchi G; Hewetson J; Henle W; Henle G
    J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Wilson G; Miller G
    Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 10. A practical and quantitative microtest for determination of neutralizing antibodies against Epstein-Barr virus.
    Rocchi G; Hewetson JF
    J Gen Virol; 1973 Mar; 18(3):385-91. PubMed ID: 4348798
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells.
    Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M
    Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
    Sairenji T; Hinuma Y
    Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
    Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
    Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
    Demissie A
    J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
    Hilgers F; Rosén A; Lamon E; Klein G
    J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
    Shapiro IM; Luka J; Andersson-Anvret M; Klein G
    Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.